Join our daily newsletter At The Bell to receive exclusive market insights
- Q4 revenue hits record US$1.5 billion
- Up 8.0% on a constant currency basis
- Q4 GAAP diluted earnings per share up 2.0%
- Returned $1.0 billion to shareholders through share repurchases and dividends
AI-powered digital health solutions specialist Resmed Inc. (ASX:RMD) has unveiled impressive results for its quarter ended June 30, 2026.
Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.
“We closed fiscal year 2026 with strong fourth quarter results, reflecting continued momentum of our global business, sustained demand for our market-leading products, and disciplined execution of our strategy,” chairman and CEO, Mick Farrell, said.
“Year-over-year, we delivered 9.0% reported revenue growth, 90 basis points of gross margin expansion, and a 16% increase in earnings per share.
“For full year 2026, our US$1.6 billion in free cash flow enabled us to invest in innovation, strengthen our market leadership, and return more than $1 billion to our shareholders.”
Mr Farrell told shareholders that entering fiscal year 2027, Resmed will leverage its global scale and enhance its digital capabilities to benefit patients, providers, and customers.
“We will use our industry-leading portfolio to improve patient outcomes, reduce healthcare costs, and drive long-term profitable growth for our shareholders.”
Financial highlights
• FY 2026 revenue increased by 10% to US$5.7 billion; up eight per cent on a constant currency basis
• FY 2026 GAAP gross margin up 170 bps to 61.1%; non-GAAP gross margin up 240 bps to 62.4%
• FY 2026 GAAP operating margin up 70 bps to 33.4%, non-GAAP operating margin up 180 bps to 36.1%
Guiding to more than US$1.85 billion in capital to be returned to shareholders through share repurchases and dividends during FY 2027; announced quarterly dividend increase of 10% to $0.66 per quarter.
RMD was down 4.73% to $29.99. Mkt cap $4.540B.
Join the discussion: See what HotCopper users are saying about Resmed Inc. and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
